Ag-Doped SnSe Nanosheets\nfor Enhanced NIR-II Light-Induced\nApoptosis

Triple-negative breast cancer (TNBC) is one of the most\naggressive\nand challenging subtypes with limited treatment options and poor prognosis.\nTo overcome these obstacles, Ag-doped SnSe (ASS) nanosheets were used\nas photonic hyperthermia agents for treating TNBC. ASS featured a\nhigh photothermal-conversion efficiency and photon hyperthermia effect.\nAdditionally, biosafety assessments, including hemolysis assays and\nhistopathological analysis, confirmed that ASS was biosafety. These\nfindings suggest that ASS, in synergy with the second near-infrared\nbiowindow (NIR-II) light irradiation, offers a noninvasive, effective,\nand safe therapeutic strategy for TNBC. This innovative approach exemplifies\nthe evolving landscape of TNBC treatment, where technology and biology\nconverge to offer more precise and personalized therapies.

Publication Details

Journal
Figshare
Published
2024-11-22
DOI
https://doi.org/10.1021/acsanm.4c04932.s001
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ag-Doped SnSe Nanosheets\nfor Enhanced NIR-II Light-Induced\nApoptosis

Figshare
Nanoplatforms for cancer theranostics
article

Ag-Doped SnSe Nanosheets\nfor Enhanced NIR-II Light-Induced\nApoptosis

article en

Abstract

Triple-negative breast cancer (TNBC) is one of the most\naggressive\nand challenging subtypes with limited treatment options and poor prognosis.\nTo overcome these obstacles, Ag-doped SnSe (ASS) nanosheets were used\nas photonic hyperthermia agents for treating TNBC. ASS featured a\nhigh photothermal-conversion efficiency and photon hyperthermia effect.\nAdditionally, biosafety assessments, including hemolysis assays and\nhistopathological analysis, confirmed that ASS was biosafety. These\nfindings suggest that ASS, in synergy with the second near-infrared\nbiowindow (NIR-II) light irradiation, offers a noninvasive, effective,\nand safe therapeutic strategy for TNBC. This innovative approach exemplifies\nthe evolving landscape of TNBC treatment, where technology and biology\nconverge to offer more precise and personalized therapies.

Figshare
Openalex Percentile: Top 73%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.